drugset / Trial / NCT00429754
Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate whether there is an interaction occurs between etoposide and aprepitant in patients with testis carcinoma treated with the standard BEP regimen. Also to determine how long treatment with aprepitant is necessary in BEP regimen for 5 consecutive days.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2008-09
Outcome
Outcome not reported
Stopped: “change of study population and chemotherapeutic regimen”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | — | — |
Indications
No indication recorded.